Form 4: Ensysce Biosciences Director Buys Shares
Insider Transaction (Form 4)
Bob G Gower, a Director of Ensysce Biosciences, Inc., purchased 908,614 shares of common stock on April 23, 2026.
Summary
- Open-market purchase: acquired 508,614 Common Stock at $0.48 ($246,169) on April 23, 2026; holds 516,740 after (Direct).
- Open-market purchase: acquired 400,000 Common Stock at $0.49 ($198,000) on August 7, 2026; holds 916,740 after (Direct).
- Conversion of derivative: acquired 254,307 Warrant on April 23, 2026; holds 289,836 after (Direct).
Sentiment
Score: 8
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $444,169, committing personal capital to the stock.
Insider Transactions
Bob G Gower — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-04-23 | Open-market purchase | Common Stock | 508,614 | $0 | $246.2K | 516,740 |
| 2026-08-07 | Open-market purchase | Common Stock | 400,000 | $0 | $198.0K | 916,740 |
| 2026-04-23 | Conversion of derivative | Warrant | 254,307 | — | — | 289,836 |
Key Dates
| Date | Description |
|---|---|
| 2026-04-23 | Open-market purchase (508,614 shares) |
| 2026-08-07 | Open-market purchase (400,000 shares) |
| 2026-04-23 | Conversion of derivative (254,307 shares) |
Keywords
insider transaction, Form 4, ENSC, Ensysce Biosciences, Inc., bullish, Bob G Gower
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.